Results 71 to 80 of about 1,456 (148)

Visual Snow Syndrome: Seeing Snowflakes, a Unique Visual Phenomenon Following Mild Traumatic Brain Injury

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Visual Snow Syndrome (VSS) can occur after a variety of triggers including mild traumatic brain injury (mTBI). Rehabilitation providers frequently evaluate patients following mTBIs. It is vital for rehabilitation providers to include VSS on their differential diagnosis to facilitate appropriate referrals to Ophthalmology for evaluation and ...
Sarah Matthews   +3 more
wiley   +1 more source

Diagnostic Performance of Mobile Low‐Field MRI and CT for Acute Headache as the Isolated Clinical Manifestation in the Neurology Emergency Department

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 8, August 2026.
For emergency patients with headaches as the initial and isolated clinical manifestation, mLF‐MRI may serve as a supplementary diagnostic imaging modality that provides additional diagnostic information in selected ED settings. mLF‐MRI, especially FLAIR sequences, demonstrates high CT‐referenced diagnostic concordance for SAH and can also detect early ...
Xinyan Hu   +15 more
wiley   +1 more source

An Open‐Label, 2‐Period, Fixed Sequence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder), with and without Concomitant Itraconazole in Healthy Adult Subjects

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 8, August 2026.
Abstract Dihydroergotamine (DHE) prescribing information contains a boxed warning regarding the possibility of serious and/or life‐threatening peripheral ischemia with co‐administration of strong cytochrome P450 3A4 (CYP3A4) inhibitors. The effects of the strong CYP3A4 inhibitor itraconazole on the pharmacokinetics and safety of nasally administered ...
Detlef Albrecht   +2 more
wiley   +1 more source

Integrated Clinical Trial and Molecular Profiling Reveals Immune Drivers of Chronic Hand Eczema

open access: yesAllergy, Volume 81, Issue 8, Page 2815-2832, August 2026.
This study performed an unbiased molecular profiling of CHE patients across diverse etiologies to identify shared pathogenic drivers and evaluate the impact of IL‐4Rα blockade via dupilumab over 16 weeks. CHE shows a mixed immune signature involving type 1, 2, and 3 pathways with features of atopic dermatitis and psoriasis.
Perrine Gery   +25 more
wiley   +1 more source

Multivalent antibody‐based conjugates as new tools for tailored modulation of G protein–coupled receptors

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 16, Page 4512-4531, August 2026.
The G protein–coupled receptor (GPCR) superfamily consists of the most common targets of approved drugs. Targeting GPCRs offers appealing avenues for therapeutic development. Antibodies and their fragments, such as single‐domain antibodies (VHHs or nanobodies), have emerged as useful alternatives to small molecule pharmacophores as building blocks in ...
Shivani Sachdev, Ross W. Cheloha
wiley   +1 more source

Migraine in Young Stroke Patients—Better Outcomes Despite Distinct Risk Profiles: Insights From the STROKE‐CARD‐Study

open access: yesEuropean Journal of Neurology, Volume 33, Issue 8, August 2026.
Among young adults with ischaemic stroke, migraine—particularly with aura—was associated with younger stroke onset and a higher prevalence of PFO. Vascular risk profiles and stroke characteristics were similar across groups. Migraine patients showed more favourable short‐term outcomes.
Katharina Kaltseis   +40 more
wiley   +1 more source

What does a migraine aura look like?—A systematic review

open access: yesThe Journal of Headache and Pain
Migraine with aura is a prevalent neurological disorder that affects up to 30% of individuals experiencing migraines. It presents as temporary neurological disturbances, primarily visual, but also includes sensory, speech, motor, and brainstem symptoms ...
Ľubica Joppeková   +10 more
doaj   +1 more source

Pizotifen relieves acute migraine symptoms

open access: yesLibyan Journal of Medicine, 2008
To The Editor: Various pharmacological agents are used for the treatment of migraine. In the last five years, various drug companies in Bangladesh have been marketing pizotifen as a preventive treatment of all types of migraine.
A.S.M. Kamrul Huda
doaj  

Doppler monitoring of preventive migraine treatment

open access: yesJournal of Education, Health and Sport
The article presents an analysis of literature data and the results of our own clinical and Doppler examination of 116 young patients with migraine. (18-45 years old), a clinical and neurological examination was performed, an assessment of the intensity
V. Kalashnikov   +2 more
doaj   +1 more source

Reduced neurovascular coupling of the visual network in migraine patients with aura as revealed with arterial spin labeling MRI: is there a demand-supply mismatch behind the scenes?

open access: yesThe Journal of Headache and Pain
Background Although neuroimaging investigations have consistently demonstrated that “hyperresponsive” and “hyperconnected” visual cortices may represent the functional substrate of cortical spreading depolarization in patients with migraine with aura ...
Marcello Silvestro   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy